Table 1.

Summary of COVID-19 cohort characteristics

Cohort Characteristics	N (%)
Male	24 (66.7)
Race (White)	18 (77.8)
BMI > 30	23 (63.9)
ARDS diagnosis	24 (66.7)
Antibiotics	26 (73.0)
Corticosteroid therapy	29 (81.1)
Hemodialysis	6 (16.7)
Thrombosis	11 (30.8)
Deceased	9 (25.0)
	Median [IQR]
Age (years)	64.5 [56.5, 71.8]
# days from ICU admission t1 (n = 22)	7 [3.0, 10.5]
# days from hospital admission t1 (n = 14)	1 [0, 2]
ICUFD	21.5 [-0.75, 28]
t1 SOFA-score	2.5 [1.0, 6.8]
t2 SOFA-score	1 [0, 4.8]
t1 SF-ratio	242.5 [135.3, 350.8]
t2 SF-ratio	334.5 [241.0, 441.8]
t1 NLR	7.7 [4.9, 14.6]
t1 ANC	4.3 [1.5, 8.9]
% t1 [DEspR + CD11b + NET + Ns]	53.85 [28.2, 68.6]
% t1 [DEspR + CD11b + NET(-) Ns]	46.15 [31.5, 71.8]
% t1 [DEspR(-)CD11b( ±) NET + Ns]	0.94 [0.17, 3.00]
# t1 [DEspR + CD11b + NET + Ns] K/μL	0.18 [0.02, 0.95]
# t1 [DEspR + CD11b + NET(-) Ns] K/μL	0.15 [0.018, 1.1]
# t1 [DEspR(-)CD11b( ±) NET + Ns] K/μL	0.03 [0.006, 0.080]
	Ave [min–max]
# t1 [DEspR + CD11b + NET + Ns] K/μL	1.53 [0–15.4]
# t1 [DEspR + CD11b + NET(-) Ns] K/μL	1.08 [0–7.9]
# t1 [DEspR(-)CD11b( ±) NET + Ns] K/μL	0.11 [0–0.84